Approval · Notice of Compliance 10154 · 2009
HUMALOG: Notice of Compliance 10154
Issued April 15, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10154
- Date
- April 15, 2009
- Company
- Eli Lilly Canada IncToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional drug product manufacturing facility, changes to drug product batch size, manufacturing process and in-process controls
- Therapeutic class
- Antidiabetic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HUMALOG | Not yet assigned | — |
Medicinal ingredients
- INSULIN LISPRO 100 UNIT per ML